We begin tonight with the restart of the one- dose
Johnson & Johnson vaccine, once considered a game
changer in the fight against the coronavirus. The CDC
lifting its 11- day pause after 15 cases of rare blood
clots were identified. Three women died. That's out of
8 million shots administered. Nearly half of all states
now promising to resume the Johnson & Johnson
vaccine. Doses will come with a warning label about
the rare potential for blood clots. Overall, nearly 36 %
of the adult population now fully vaccinated but tonight
new signs that supply is beginning to outpace demand.
Some states asking for smaller shipments of vaccine.
New York City vaccination sites now accepting
walk- ins, no appointment needed. ABC's elwyn Lopez
leading us off from Atlanta. Reporter:
Tonight, after an 11 day pause, the Johnson & Johnson
vaccine getting the green light. I think the benefits
outweigh the risks. Reporter: At least 22 states saying
they'll resume the one- dose shots immediately. What
would you say to people who are hesitant? I would say
look at the facts, trust science. Reporter: The CDC and
the fda recommending j & j's shot come with a label
warning of the risk of rare blood clots. So far, 15
blood clot cases verified, but with 8 million shots given,
that's about 1 clot per 500, 000 vaccines given.
Experts say things like birth control and cigarettes, that
some Americans use everyday, are exceedingly more
likely to give you a blood clot than the rare but
potentially deadly type from the shot. The risk of you
having this complication versus the potential risk of
getting covid right now certainly is on the side of
getting covid. Reporter: Over the past nine days, the
average number of daily vaccines administered
dropping nearly 16 %. And with supply outpacing
demand, some states like Louisiana and Mississippi
now asking for fewer doses. Adding to growing
concerns that vaccine hesitancy could trigger spikes in
cases. We're at a really critical moment. If we hit a
plateau in getting shots into people, we have this
concern about a potential new wave. In New York,
city- run vaccine sites like this one now opening its
doors. Walk- ins welcome to anyone 16 and over,
appointments no longer needed. I've been taking all
sorts of precautions, but I really need to get one, and I
think everyone should get one. Elwyn Lopez joins us
now from CDC headquarters in Atlanta. Elwyn, as the
Johnson & Johnson vaccine comes back online, you're
hearing from some of the top pharmacies in the
country on their plans to start administering shots
again. Reporter: That's right, whit. With 9 million doses
prepared to go into the arms of Americans,
pharmacies like CVS and Walgreens telling me they
expect to resume the use of single- dose vaccines
starting next week. Whit? Elwyn Lopez for us. Thank
you.